S.Biomedics Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	6,191	4,484	1,410	4,066	6,131	9,188
Short-Term Investments	-	7,746	8,175	2,346	6,750	3,000
Trading Asset Securities	12,238	11,720	1,073	1,007	-	259.94
Cash & Short-Term Investments	18,429	23,950	10,658	7,419	12,881	12,448
Cash Growth	32.91%	124.71%	43.66%	-42.41%	3.48%	-20.17%
Accounts Receivable	1,153	1,753	1,922	1,246	388.8	713.77
Other Receivables	-	206.19	198.83	204.02	67.26	65.95
Receivables	1,153	2,050	2,211	1,540	456.07	789.71
Inventory	2,258	2,325	2,369	1,570	763.73	707.72
Prepaid Expenses	-	404.79	336.37	426	174.46	254.73
Other Current Assets	976.19	542.39	126.94	245.98	66.43	121.3
Total Current Assets	22,817	29,272	15,700	11,201	14,342	14,322
Property, Plant & Equipment	12,255	4,475	4,962	2,765	3,051	3,357
Long-Term Investments	734.72	500	1,533	1,000	0.06	0.04
Other Intangible Assets	290.77	407.86	118.78	153.76	25.44	19.32
Long-Term Deferred Tax Assets	436.3	436.96	358.55	412.76	-	-
Other Long-Term Assets	3,675	9,509	9,275	8,825	377.05	366.79
Total Assets	40,209	44,601	31,947	24,358	17,796	18,065
Accounts Payable	117.26	186.75	479.48	416.17	36.31	505.44
Accrued Expenses	212	266.11	294.48	253.98	182.96	138.66
Short-Term Debt	1,705	1,841	3,547	5,807	1,916	3,231
Current Portion of Long-Term Debt	353.02	6,591	338.51	331.66	96.02	88.94
Current Portion of Leases	387.41	911.85	804.99	442.6	492.23	441.04
Current Income Taxes Payable	65.97	126.69	39.1	13.46	-	-
Current Unearned Revenue	-	4.17	4.32	4.28	7.53	7.58
Other Current Liabilities	2,005	1,843	2,144	4,562	1,444	2,350
Total Current Liabilities	4,846	11,770	7,652	11,831	4,175	6,763
Long-Term Debt	11,501	9,256	6,480	7,008	3,783	1,392
Long-Term Leases	218.3	182.49	824.86	206.79	520.66	449.83
Long-Term Unearned Revenue	2,043	2,046	2,050	2,054	2,058	2,062
Pension & Post-Retirement Benefits	2,423	2,087	1,653	1,600	1,370	1,119
Other Long-Term Liabilities	5,799	948.91	932.98	622.38	2,058	1,480
Total Liabilities	26,829	26,289	19,593	23,323	13,964	13,265
Common Stock	5,972	5,873	5,669	5,110	5,110	5,075
Additional Paid-In Capital	78,579	76,481	64,803	44,478	44,478	43,936
Retained Earnings	-82,605	-74,983	-68,269	-57,759	-51,485	-45,844
Comprehensive Income & Other	3,899	4,494	4,809	4,393	4,408	2,649
Total Common Equity	5,846	11,865	7,011	-3,779	2,510	5,816
Minority Interest	7,534	6,447	5,343	4,814	1,321	-1,017
Shareholders' Equity	13,379	18,311	12,354	1,035	3,832	4,800
Total Liabilities & Equity	40,209	44,601	31,947	24,358	17,796	18,065
Total Debt	14,165	18,781	11,995	13,796	6,808	5,602
Net Cash (Debt)	4,264	5,168	-1,337	-6,377	6,073	6,846
Net Cash Growth	74.73%	-	-	-	-11.29%	-38.18%
Net Cash Per Share	360.90	449.30	-122.35	-624.02	598.26	677.20
Filing Date Shares Outstanding	11.94	11.75	11.34	10.22	10.22	10.15
Total Common Shares Outstanding	11.94	11.75	11.34	10.22	10.22	10.15
Working Capital	17,971	17,502	8,048	-629.62	10,167	7,559
Book Value Per Share	489.38	1010.11	618.41	-369.73	245.64	573.05
Tangible Book Value	5,555	11,457	6,892	-3,932	2,485	5,797
Tangible Book Value Per Share	465.04	975.39	607.93	-384.77	243.15	571.15
Land	4,070	453.44	241.82	241.82	117.16	117.16
Buildings	3,156	902.12	558.2	558.2	349.29	349.29
Machinery	7,189	7,007	6,061	4,849	4,552	4,091
Construction In Progress	2,846	24	829.26	441.24	42.5	5.4

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.